US jury says Apple must pay Masimo $634 million in smartwatch patent case

Core Viewpoint - A federal jury in California has ruled that Apple must pay Masimo $634 million for infringing on a patent related to blood-oxygen reading technology [1] Company Summary - Apple is facing a significant financial liability due to the jury's decision, which could impact its financial performance and market perception [1] - Masimo, a medical-monitoring technology company, has successfully defended its patent rights, potentially enhancing its market position and credibility in the healthcare technology sector [1]